Humulin R U-100 Insulin (hi-210)

Manufacturer LILLY Active Ingredient Insulin Regular (U-100) Vials(IN soo lin REG yoo ler) Pronunciation IN-soo-lin REG-yoo-ler
It is used to lower blood sugar in patients with high blood sugar (diabetes).
đŸˇī¸
Drug Class
Antidiabetic Agent
đŸ§Ŧ
Pharmacologic Class
Insulin, Short-Acting
🤰
Pregnancy Category
Category B
✅
FDA Approved
Oct 1982
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Insulin Regular is a short-acting insulin used to control high blood sugar in people with diabetes. It works by helping your body use sugar for energy and by reducing the amount of sugar your liver makes. It's typically injected under the skin about 30 minutes before meals.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue under the skin in the upper arm, thigh, buttocks, or stomach area. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.

Before use, wash your hands thoroughly. It is recommended to take this medication 30 minutes before meals. To minimize the risk of injection site reactions, rotate the injection site with each dose.

Important Administration Guidelines

Do not shake the medication before use.
Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
Do not use the medication if the solution appears cloudy, is leaking, or contains particles, or if the solution has changed color.
Dispose of needles and syringes in a designated sharps disposal container. Do not reuse needles or other equipment.

Additional Administration Information

This medication may be administered intravenously by a healthcare provider.
If instructed by your doctor, this medication can be mixed with insulin NPH. However, do not mix it with other types of insulin.
Certain brands of this medication may not be suitable for use in an insulin pump, unless specified by your doctor. If using an insulin pump, consult with your doctor or pharmacist to ensure the compatibility of your medication.
If using this medication in a pump, follow the instructions provided by your doctor or the package insert. Regularly change the medication and pump parts as directed.

Diet and Exercise

Follow the diet and exercise plan recommended by your doctor. Be aware of the steps to take if you miss a meal or do not eat as much as usual.

Storage and Disposal

Store unopened containers of this medication in the refrigerator. Do not freeze the medication, and do not use it if it has been frozen.

Missed Doses

If you forget to take a dose, consult with your doctor for guidance on what to do next. If you are unsure about the proper course of action, contact your doctor for advice.
💡

Lifestyle & Tips

  • Follow your prescribed diet plan, which should be balanced and consistent in carbohydrate intake.
  • Engage in regular physical activity as advised by your healthcare provider. Exercise can lower blood sugar, so you may need to adjust your insulin dose or eat a snack before/after exercise.
  • Monitor your blood glucose levels regularly as instructed by your doctor. This is crucial for adjusting insulin doses and preventing complications.
  • Learn to recognize and treat symptoms of low blood sugar (hypoglycemia). Always carry a source of fast-acting sugar (e.g., glucose tablets, fruit juice, hard candy).
  • Rotate injection sites to prevent skin problems like lumps or indentations (lipodystrophy).
  • Store insulin properly: unopened vials in the refrigerator, opened vials at room temperature (below 86°F/30°C) for up to 28 days.
  • Never share needles, syringes, or insulin pens with others, even if the needle is changed. This can transmit infections.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Individualized based on metabolic needs, blood glucose monitoring, and glycemic goals. Typically administered 30 minutes before a meal.

Condition-Specific Dosing:

Type 1 Diabetes: Initial total daily dose often 0.5-1.0 units/kg/day, with 1/3 to 1/2 as basal insulin and the remainder as prandial insulin divided before meals. Regular insulin is used for prandial coverage.
Type 2 Diabetes: Initial dose often 0.1-0.2 units/kg/day or 4-6 units once daily, adjusted based on blood glucose. Regular insulin may be added to basal insulin or used in multiple daily injections.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (highly individualized, often in hospital settings)
Infant: Individualized based on metabolic needs and blood glucose monitoring. Dosing is highly variable and requires close supervision.
Child: Individualized based on metabolic needs and blood glucose monitoring. Initial total daily dose often 0.5-1.0 units/kg/day, with regular insulin used for prandial coverage.
Adolescent: Individualized based on metabolic needs and blood glucose monitoring. Dosing may increase during puberty due to insulin resistance.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: May require dose reduction due to decreased insulin clearance and increased risk of hypoglycemia. Monitor blood glucose closely.
Moderate: Requires dose reduction due to decreased insulin clearance and increased risk of hypoglycemia. Monitor blood glucose closely.
Severe: Requires significant dose reduction due to decreased insulin clearance and increased risk of hypoglycemia. Monitor blood glucose closely and frequently.
Dialysis: Dose reduction is typically required. Insulin requirements may fluctuate. Close monitoring of blood glucose is essential.

Hepatic Impairment:

Mild: May require dose reduction due to decreased gluconeogenesis and altered insulin metabolism. Monitor blood glucose closely.
Moderate: Requires dose reduction due to decreased gluconeogenesis and altered insulin metabolism. Monitor blood glucose closely.
Severe: Requires significant dose reduction due to decreased gluconeogenesis and altered insulin metabolism. Monitor blood glucose closely and frequently.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Insulin Regular (human insulin) lowers blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis and proteolysis, and enhances protein synthesis.
📊

Pharmacokinetics

Absorption:

Bioavailability: Highly variable (approximately 50-60% subcutaneously due to degradation and absorption variability)
Tmax: Subcutaneous: 2-3 hours
FoodEffect: Administered 30 minutes before a meal to coincide with postprandial glucose rise.

Distribution:

Vd: Approximately 0.1 L/kg
ProteinBinding: Low (approximately 0-10%)
CnssPenetration: Limited

Elimination:

HalfLife: Subcutaneous: Approximately 1.5-4 hours (functional half-life, reflecting absorption and elimination)
Clearance: Approximately 0.8-1.0 L/kg/hr
ExcretionRoute: Renal (approximately 20-30% of clearance)
Unchanged: Less than 5%
âąī¸

Pharmacodynamics

OnsetOfAction: Subcutaneous: 30-60 minutes
PeakEffect: Subcutaneous: 2-5 hours
DurationOfAction: Subcutaneous: 6-10 hours
Confidence: Medium

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Some allergic reactions can be life-threatening, so prompt medical attention is crucial.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Swelling in the arms or legs
Thick skin, pits, or lumps at the injection site
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures

If you experience any of these symptoms, call your doctor right away. If you have low blood sugar, follow the instructions you have been given, which may include taking glucose tablets, liquid glucose, or some fruit juices.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have minor ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Weight gain
Irritation at the injection site

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Symptoms of low blood sugar (hypoglycemia): sweating, trembling, dizziness, confusion, hunger, irritability, blurred vision, rapid heartbeat, headache, slurred speech, seizures, unconsciousness.
  • Symptoms of high blood sugar (hyperglycemia): increased thirst, frequent urination, increased hunger, fatigue, blurred vision, weight loss, nausea, vomiting, fruity breath odor (sign of ketoacidosis).
  • Signs of allergic reaction: rash, itching, hives, swelling of face/lips/tongue/throat, difficulty breathing, wheezing, rapid heart rate, sweating, feeling faint.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have low blood sugar (hypoglycemia), as this may affect your treatment plan.

Additionally, this medication may interact with other health conditions or medications. To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are currently taking
Any natural products or vitamins you are using
* Your complete medical history, including any health problems you have or have had in the past

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm that it is safe to do so. This will help prevent any potential interactions or adverse effects.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Ensure you have the correct insulin product, as it comes in various containers such as vials, cartridges, and pens. Understand how to measure and prepare your dose accurately. If you have any questions or concerns, consult your doctor or pharmacist.

Be aware that this medication can cause low blood sugar (hypoglycemia), which may lead to seizures, loss of consciousness, permanent brain damage, and even death if not treated promptly. Discuss the risks and management of low blood sugar with your doctor.

Additionally, this medication can cause low blood potassium (hypokalemia), which, if left untreated, may result in abnormal heart rhythms, severe breathing difficulties, and potentially death. Consult your doctor if you experience any symptoms.

Until you understand how this medication affects you, avoid driving and other activities that require alertness. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure when used with insulin. If you are taking one of these medications, discuss the potential risks with your doctor.

During periods of stress, such as fever, infection, injury, or surgery, your blood sugar levels may be more challenging to control. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.

To ensure your safety, wear a medical alert identification (ID) that indicates your condition. Avoid driving if you have experienced low blood sugar, as it increases the risk of accidents. Monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as recommended.

Before consuming alcohol or using products containing alcohol, consult your doctor. Never share your insulin product, including pens, cartridge devices, needles, or syringes, with others, even if the needle has been changed, as this can transmit infections.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the benefits and risks of this medication for both you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypoglycemia (extremely low blood sugar)
  • Confusion
  • Drowsiness
  • Blurred vision
  • Slurred speech
  • Muscle weakness
  • Seizures
  • Loss of consciousness
  • Coma

What to Do:

For mild to moderate hypoglycemia, consume 15-20 grams of fast-acting carbohydrates (e.g., 4 oz fruit juice, 3-4 glucose tablets). Recheck blood glucose in 15 minutes and repeat if still low. For severe hypoglycemia (unconsciousness or inability to swallow), administer glucagon injection (if available and trained) and seek immediate emergency medical attention. Call 911 or 1-800-222-1222 (Poison Control).

Drug Interactions

🔴

Major Interactions

  • Beta-blockers (may mask symptoms of hypoglycemia, prolong hypoglycemia)
  • Thiazolidinediones (TZDs) (increased risk of fluid retention and heart failure when used with insulin)
  • Alcohol (may potentiate hypoglycemic effect)
🟡

Moderate Interactions

  • Corticosteroids (may increase blood glucose, requiring higher insulin doses)
  • Diuretics (thiazide and loop diuretics may increase blood glucose)
  • Sympathomimetics (e.g., decongestants, asthma medications; may increase blood glucose)
  • Atypical antipsychotics (may cause hyperglycemia)
  • Protease inhibitors (may cause hyperglycemia)
  • Somatostatin analogs (e.g., octreotide, lanreotide; may decrease insulin requirements)
  • Salicylates (e.g., aspirin in large doses; may enhance hypoglycemic effect)
  • Sulfonamide antibiotics (may enhance hypoglycemic effect)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Glycated Hemoglobin (HbA1c)

Rationale: To establish baseline glycemic control and set treatment goals.

Timing: Prior to initiation of insulin therapy.

Fasting Plasma Glucose (FPG)

Rationale: To establish baseline glucose levels.

Timing: Prior to initiation of insulin therapy.

Renal Function (e.g., SCr, eGFR)

Rationale: To assess kidney function, as insulin clearance can be affected by renal impairment.

Timing: Prior to initiation and periodically thereafter.

Hepatic Function (e.g., ALT, AST)

Rationale: To assess liver function, as insulin metabolism can be affected by hepatic impairment.

Timing: Prior to initiation and periodically thereafter.

📊

Routine Monitoring

Self-Monitoring Blood Glucose (SMBG)

Frequency: Multiple times daily (e.g., pre-meal, 2-hour post-meal, bedtime, overnight as needed)

Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL post-meal

Action Threshold: Adjust insulin dose based on patterns of hyperglycemia or hypoglycemia; seek medical advice for persistent out-of-range values.

Glycated Hemoglobin (HbA1c)

Frequency: Every 3-6 months

Target: Individualized, typically <7% for most adults

Action Threshold: Adjust insulin regimen if HbA1c is above target; investigate causes of poor control.

Signs and Symptoms of Hypoglycemia

Frequency: Daily, with each insulin dose and throughout the day

Target: N/A

Action Threshold: Treat immediately with fast-acting carbohydrates if blood glucose <70 mg/dL or symptoms present. Adjust insulin dose to prevent recurrence.

Injection Site Inspection

Frequency: Regularly (e.g., daily or weekly)

Target: N/A

Action Threshold: Rotate injection sites to prevent lipodystrophy (lipoatrophy or lipohypertrophy).

đŸ‘ī¸

Symptom Monitoring

  • Symptoms of hypoglycemia (e.g., sweating, trembling, dizziness, confusion, hunger, irritability, blurred vision, rapid heartbeat)
  • Symptoms of hyperglycemia (e.g., increased thirst, frequent urination, increased hunger, fatigue, blurred vision, weight loss)
  • Signs of allergic reaction (e.g., rash, itching, swelling, difficulty breathing)
  • Signs of injection site reactions (e.g., redness, swelling, itching, pain, lipodystrophy)

Special Patient Groups

🤰

Pregnancy

Insulin is the preferred treatment for glycemic control in pregnant women with pre-existing diabetes or gestational diabetes. It does not cross the placenta in significant amounts and is considered safe and effective for both mother and fetus. Close monitoring of blood glucose is essential, and insulin requirements may change throughout pregnancy.

Trimester-Specific Risks:

First Trimester: Insulin requirements may decrease due to nausea/vomiting. Strict glycemic control is crucial to reduce risk of congenital malformations.
Second Trimester: Insulin requirements typically increase due to increasing insulin resistance.
Third Trimester: Insulin requirements continue to increase, often peaking in the late third trimester. Close monitoring is needed to prevent macrosomia and other complications.
🤱

Lactation

Insulin is compatible with breastfeeding. It is a large protein molecule and is not excreted into breast milk in clinically significant amounts. Insulin requirements may be lower during lactation compared to pre-pregnancy levels.

Infant Risk: L1 (Safest - no known adverse effects on the infant).
đŸ‘ļ

Pediatric Use

Insulin Regular is used in pediatric patients with type 1 and type 2 diabetes. Dosing is highly individualized based on age, weight, pubertal status, activity level, and glycemic targets. Close monitoring of blood glucose is essential to prevent hypoglycemia and ensure optimal growth and development.

👴

Geriatric Use

Elderly patients may be more susceptible to hypoglycemia due to impaired renal/hepatic function, reduced counter-regulatory responses, and polypharmacy. Dosing should be initiated cautiously and titrated slowly with careful monitoring of blood glucose. Glycemic targets may be less stringent to avoid hypoglycemia.

Clinical Information

💎

Clinical Pearls

  • Humulin R U-100 is a short-acting insulin, meaning it starts working relatively quickly and has a shorter duration compared to intermediate or long-acting insulins. It is typically used to cover mealtime glucose excursions.
  • Always administer Humulin R 30 minutes before a meal to allow time for the insulin to start working and prevent post-meal hyperglycemia.
  • Ensure patients understand the difference between U-100 (100 units/mL) and U-500 (500 units/mL) insulin to prevent dosing errors. U-100 insulin should only be drawn up with U-100 syringes.
  • Teach patients proper injection technique, including site rotation, to prevent lipodystrophy, which can impair insulin absorption.
  • Stress the importance of consistent carbohydrate intake and meal timing when using regular insulin to match insulin action with food intake.
  • Patients should be educated on the signs and symptoms of hypoglycemia and how to treat it promptly. Always carry a source of fast-acting carbohydrates.
  • Unopened vials should be stored in the refrigerator (36°F-46°F [2°C-8°C]). Opened vials can be stored at room temperature (below 86°F [30°C]) for up to 28 days. Do not freeze insulin.
🔄

Alternative Therapies

  • Rapid-acting insulins (e.g., insulin lispro, insulin aspart, insulin glulisine): Faster onset and shorter duration, often preferred for mealtime coverage due to greater flexibility.
  • Intermediate-acting insulins (e.g., NPH insulin): Provide basal and some prandial coverage, but have a less predictable peak.
  • Long-acting insulins (e.g., insulin glargine, insulin detemir, insulin degludec): Provide basal insulin coverage for 24 hours or more.
  • Premixed insulins (e.g., 70/30 NPH/Regular): Combine intermediate and short-acting insulin for convenience.
  • Oral antidiabetic agents (e.g., metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists): Used for type 2 diabetes, often before insulin initiation or in combination with basal insulin.
💰

Cost & Coverage

Average Cost: $25 - $100 per 10 mL vial (U-100)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (often preferred formulary status due to cost-effectiveness)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to facilitate prompt and effective treatment.